Baker Brothers Life Sciences Capital (GP), LLC Insider Trading $NRGN NEUROGEN CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).

Baker Brothers Life Sciences Capital (GP), LLC in NEUROGEN CORP

Trading Symbol: NRGN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 3,678,823 shares
Latest Transaction: Nov 13 2008

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC in NEUROGEN CORP

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO, VPHM

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 13 2008NRGNNEUROGEN CORPBaker Brothers Life Sciences C ...DirectorOption ExerciseC0.0052,73700
Nov 13 2008NRGNNEUROGEN CORPBaker Brothers Life Sciences C ...DirectorBuyC0.001,371,16203,678,8232.3 M to 3.7 M (+59.42 %)
Apr 15 2008NRGNNEUROGEN CORPBaker Brothers Life Sciences C ...DirectorOption ExerciseP2.3052,737121,29552,737
Apr 15 2008NRGNNEUROGEN CORPBaker Brothers Life Sciences C ...DirectorOption ExerciseP0.0052,737052,737

Page:   1